Private company
Paragon 28, Inc.
American surgical and medical instruments and apparatus company.
Last updated Oct 18, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
74.7%Gross margin3
-15.9%Operating margin3
-21.3%Net margin3
18.4%Revenue growth, 20243
-41.8%Return on equity3
0.84×Debt to equity3
Where the money goes
Where each dollar of revenue went, fiscal 2024
- Cost of revenue22¢$64.7M
- Research and development9¢$27.1M
- Selling, general and admin69¢$205.2M
- Income tax0¢$1.2M
Out of $256.2M in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | $106.3M4 | $111.0M5 | $147.5M6 | $181.4M3 | $216.4M3 | $256.2M3 | |
| Cost of revenue | $18.8M4 | $25.1M5 | $28.0M6 | $32.1M3 | $52.0M3 | $64.7M3 | |
| Gross profit | $87.4M4 | $85.9M5 | $119.4M6 | $149.3M3 | $164.4M3 | $191.5M3 | |
| Research and development | $10.3M4 | $11.2M5 | $16.1M6 | $24.6M3 | $30.1M3 | $27.1M3 | |
| Selling, general and admin | $74.4M4 | $72.6M5 | $114.1M6 | $159.3M3 | $180.0M3 | $205.2M3 | |
| Operating income | $2.7M4 | $2.1M5 | -$10.8M6 | -$61.7M3 | -$45.7M3 | -$40.8M3 | |
| Income tax | -$1.1M4 | $1.5M5 | $713.0K6 | -$64.0K3 | $213.0K3 | $1.2M3 | |
| Net income | $3.1M4 | $3.5M5 | -$13.7M6 | -$65.6M3 | -$57.5M3 | -$54.6M3 | |
| Earnings per share | $0.074 | $0.065 | -$0.266 | -$0.863 | -$0.703 | -$0.663 | |
| Earnings per share (diluted) | $0.054 | $0.045 | -$0.266 | -$0.863 | -$0.703 | -$0.663 |
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Cash | $2.6M5 | $17.5M6 | $109.4M3 | $38.5M6 | $75.6M3 | $34.6M3 | |
| Current assets | $71.8M4 | $179.5M5 | $142.7M6 | $207.8M3 | $168.8M3 | ||
| Total assets | $97.6M4 | $234.5M5 | $255.8M6 | $332.7M3 | $290.7M3 | ||
| Current liabilities | $22.1M4 | $34.0M5 | $68.5M6 | $51.2M3 | $48.1M3 | ||
| Long-term debt | $4.0M4 | $7.5M5 | $42.2M6 | $109.8M3 | $110.0M3 | ||
| Total liabilities | $26.1M4 | $42.4M5 | $113.2M6 | $163.0M3 | $160.1M3 | ||
| Shareholders’ equity | $21.9M4 | $23.0M5 | $30.4M6 | $192.2M3 | $142.6M3 | $169.7M3 | $130.6M3 |
| Shares outstanding | 46.7M shares4 | 76.4M shares5 | 77.8M shares6 | 82.8M shares3 | 83.9M shares3 |
Leadership
Who has led Paragon 28, Inc., and when. Pick a name to see everywhere that person has worked.
Chief financial officer
2025
- Chief financial officerStephen Deitsch Oct 14, 2021 to now10
Board members and other officers (20)
- EVP of Research & DevelopmentAndrew James Hill Mar 12, 2024 to now11
- OfficerChadi Chahine Aug 8, 2024 to now12
- OfficerRobert S. McCormack Aug 16, 2023 to now13
- Chief Accounting OfficerErik E. Mickelson Apr 13, 2022 to now14
- Chief Technology OfficerJason Allan Edie Apr 20, 2022 to Mar 2, 202315
- OfficerAlbert Dacosta Oct 14, 2021 to now16
- Chief Technology OfficerFrank S. Bono Oct 14, 2021 to Jun 8, 202217
- Chief Commercial OfficerMatthew Jarboe Oct 14, 2021 to now18
- Board memberDavid M. Demski Dec 12, 2024 to now19
- Board memberMeghan Scanlon Apr 5, 2022 to now20
- Board memberLee Rosenthal Jul 21, 2022 to Jul 21, 202221
- Board memberQuentin S. Blackford Aug 4, 2022 to now22
- Board memberAlbert Dacosta Oct 14, 2021 to now16
- Board memberAlf Grunwald Oct 14, 2021 to now23
- Board memberScott William Drake Oct 14, 2021 to May 20, 202224
- Board memberStephen N. Oesterle Oct 14, 2021 to now25
- Board memberThomas P. Schnettler Oct 14, 2021 to now26
- Board memberB. Kristine Johnson Dec 3, 2021 to now27
- Board memberKristina Wright Dec 3, 2021 to now28
- General counselJonathan I. Friedman Oct 14, 2021 to Mar 2, 202329
Timeline
- Oct 8, 2021Founded Paragon 28, Inc. is founded30
Filings
315 filings to the SEC since October 2021: 6 annual reports, 11 quarterly reports, 43 major events, 174 insider forms, 18 large holders, 63 other. The latest 20:
- May 15, 2025SCHEDULE 13G/A EDGAR
- May 12, 2025SCHEDULE 13G/A EDGAR
- May 1, 202515-12G EDGAR
- Apr 24, 2025EFFECT EDGAR
- Apr 21, 202510-K/A EDGAR
- Apr 21, 20254 EDGAR
- Apr 21, 20254 EDGAR
- Apr 21, 20254 EDGAR
- Apr 21, 20254 EDGAR
- Apr 21, 20254 EDGAR
- Apr 21, 20254 EDGAR
- Apr 21, 20254 EDGAR
- Apr 21, 20254 EDGAR
- Apr 21, 20254 EDGAR
- Apr 21, 20254 EDGAR
- Apr 21, 20254 EDGAR
- Apr 21, 20254 EDGAR
- Apr 21, 20254 EDGAR
- Apr 21, 2025S-8 POS POST-EFFECTIVE AMENDMENT NO. 1 EDGAR
- Apr 21, 2025S-8 POS POST-EFFECTIVE AMENDMENT NO. 1 EDGAR
The 315 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 18 such filings since October 2021, the latest 10:
- May 15, 2025SCHEDULE 13G/A
- May 12, 2025SCHEDULE 13G/A
- Mar 7, 2025SCHEDULE 13G/A
- Feb 28, 2025SCHEDULE 13G
- Feb 6, 2025SCHEDULE 13G/A
- Feb 5, 2025SCHEDULE 13G/A
- Jan 29, 2025SCHEDULE 13G/A
- Aug 9, 2024SC 13G
- Mar 8, 2024SCHEDULE 13G/A
- Feb 14, 2024SC 13G/A
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12SEC EDGARChadi Chahine, Officer
- 13SEC EDGARRobert S. McCormack, Officer
- 14
- 15
- 16SEC EDGARAlbert Dacosta, Officer
- 17
- 18
- 19SEC EDGARDavid M. Demski, Board member
- 20SEC EDGARMeghan Scanlon, Board member
- 21SEC EDGARLee Rosenthal, Board member
- 22SEC EDGARQuentin S. Blackford, Board member
- 23SEC EDGARAlf Grunwald, Board member
- 24SEC EDGARScott William Drake, Board member
- 25SEC EDGARStephen N. Oesterle, Board member
- 26SEC EDGARThomas P. Schnettler, Board member
- 27SEC EDGARB. Kristine Johnson, Board member
- 28SEC EDGARKristina Wright, Board member
- 29
- 30